Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (3) , 367-372
- https://doi.org/10.1023/a:1008346708604
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.Breast Cancer Research and Treatment, 1999
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administrationAnnals of Oncology, 1999
- Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing ChemotherapyJournal of Clinical Oncology, 1999
- A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.Journal of Clinical Oncology, 1998
- Phase I trial of weekly paclitaxel in advanced lung cancer.Journal of Clinical Oncology, 1998
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.Journal of Clinical Oncology, 1995
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976